QUALITY-OF-LIFE DURING TREATMENT FOR CANCER

被引：0
|
作者：
SAUNDERS, CM
BAUM, M
机构：
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 1992年 / 48卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Assessment of quality of life produces a hard outcome measure of treatment which allows us to tailor therapy to the patient's needs. This article look at ways in which quality of life can be measured and at its clinical importance in the treatment of cancer.
引用
收藏
页码：119 / 123
页数：5
相关论文
共 50 条
  • [1] ASSESSMENT OF QUALITY-OF-LIFE DURING CANCER-TREATMENT
    FAYERS, PM
    CLINICAL RADIOLOGY, 1986, 37 (03) : 301 - 301
  • [2] EVALUATION OF QUALITY-OF-LIFE DURING TREATMENT
    BERNHEIM, JL
    BULLETIN DU CANCER, 1986, 73 (05) : 614 - 619
  • [3] QUALITY-OF-LIFE - BEFORE, DURING, AND AFTER TREATMENT
    BELLETTIERI, RJ
    BREAST CANCER: FROM BIOLOGY TO THERAPY, 1993, 698 : 372 - 377
  • [4] Quality-of-life issues in the treatment of testicular cancer
    Heidenreich, A
    Hofmann, R
    WORLD JOURNAL OF UROLOGY, 1999, 17 (04) : 230 - 238
  • [5] QUALITY-OF-LIFE AFTER TREATMENT FOR TESTICULAR CANCER
    STUART, NSA
    GRUNDY, R
    WOODROFFE, C
    CULLEN, MH
    BRITISH JOURNAL OF CANCER, 1986, 54 (01) : 208 - 208
  • [6] Quality-of-life issues in the treatment of testicular cancer
    Axel Heidenreich
    Rainer Hofmann
    World Journal of Urology, 1999, 17 : 230 - 238
  • [7] CANCER AND QUALITY-OF-LIFE
    STIEFEL, F
    SUPPORTIVE CARE IN CANCER, 1995, 3 (05) : 327 - 328
  • [8] QUALITY-OF-LIFE DURING TREATMENT OF HYPERTENSIVE PATIENTS WITH DIURETICS
    VANHOOF, R
    AMERY, A
    FAGARD, R
    STAESSEN, J
    ACTA CARDIOLOGICA, 1990, 45 (05) : 393 - 401
  • [9] Quality-of-life outcomes for prostate cancer treatment in Australia
    Millar, Jeremy L.
    Evans, Susan M.
    Frydenberg, Mark
    Murphy, Declan G.
    Bolton, Damien M.
    Giles, Graham G.
    Davis, Ian D.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [10] Clinical significance of changes in quality-of-life scores during neoadjuvant treatment of esophageal cancer
    Blazeby, JM
    Nicklin, J
    Falk, SJ
    Barham, CP
    Vickers, J
    Alderson, D
    CLINICAL THERAPEUTICS, 2002, 24 : 38 - 39
12345